Skip to main content

Advertisement

Log in

Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

Removal of an infected prosthesis was considered the gold standard for eradication of infection. However, removal of well-fixed components can result in structural bone damage and compromised reconstruction. In these situations we questioned whether the infection after the total hip arthroplasty could be treated effectively and retain the well-fixed implant in a single-stage exchange.

Methods

A retrospective analysis which included 31 patients with chronic infected THA who underwent major partial single-stage revision, including routinely exchanged femoral head and liner components, aggressive soft tissue debridement, removal of the femoral stem or acetabular cup and retention of the well-fixed component, thorough exposed component brushing, and adequate surgical soaking. Powdered Vancomycin was poured into the surgical area and the infection control rate and clinical outcomes were evaluated. The failure to treat the infection was defined as a recurrence of infection in the same hip. The average follow-up was five years (2–15 years).

Result

There were four (12.9 %) failures during the study period at an average of 15 months (9–21 months) after partial single-stage revision. Of the 31 patients, 27 (87.1 %) patients had a satisfactory outcome and required no additional surgical or medical treatment for recurrence of infection. Acetabular cups were revised in 22 patients and femoral stems in nine patients. The mean post-operative Harris hip score at the most recent assessment was 74.6 (68–82).

Conclusions

Treatment of chronic infected THA with retention of the well-fixed implant in a single-stage exchange can be fairly effective in the treatment of infection and achieving acceptable functional outcomes, which indicated that this may be an attractive alternative in highly selected patients.

Level of Evidence: Level IV, therapeutic study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM (2010) Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty 25(8):1216–1222. doi:10.1016/j.arth.2009.08.011

    Article  PubMed  Google Scholar 

  2. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J (2009) Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 24(6):105–109. doi:10.1016/j.arth.2009.04.027

    Article  PubMed  Google Scholar 

  3. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ (2009) The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 91(1):128–133. doi:10.2106/JBJS.H.00155

    Article  PubMed  Google Scholar 

  4. Jafari SM, Coyle C, Mortazavi SM, Sharkey PF, Parvizi J (2010) Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop Relat Res 468:2046–2051. doi:10.1007/s11999-010-1251-6

    Article  PubMed  PubMed Central  Google Scholar 

  5. Berend KR, Lombardi AV Jr, Morris MJ, Bergeson AG, Adams JB, Sneller MA (2013) Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 471(2):510–518. doi:10.1007/s11999-012-2595-x

    Article  PubMed  Google Scholar 

  6. Gomez MM, Tan TL, Manrique J, Deirmengian GK, Parvizi J (2015) The fate of spacers in the treatment of periprosthetic joint infection. J Bone Joint Surg Am 97:1495–1502. doi:10.2106/JBJS.N.00958

    Article  PubMed  Google Scholar 

  7. Tikhilov R, Bozhkova S, Denisov A, Labutin D, Shubnyakov I, Razorenov V, Artyukh V, Klitsenko O (2016) Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. Int Orthop 40(7):1381–1387. doi:10.1007/s00264-015-3072-4

    Article  PubMed  Google Scholar 

  8. Vielgut I, Sadoghi P, Wolf M, Holzer L, Leithner A, Schwantzer G, Poolman R, Frankl B, Glehr M (2015) Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: when is the best time to perform the second stage? Int Orthop 39:1731–1736. doi:10.1007/s00264-015-2751-5

    Article  PubMed  Google Scholar 

  9. Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M (2016) One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips. Int Orthop 40(5):913–918. doi:10.1007/s00264-015-2833-4

    Article  PubMed  Google Scholar 

  10. Swarts E, Bucher TA, Phillips M, Yap FH (2015) Does the ingrowth surface make a difference? A retrieval study of 423 cementless acetabular components. J Arthroplasty 30(4):706–712. doi:10.1016/j.arth.2014.10.028

    Article  PubMed  Google Scholar 

  11. Parvizi J, Zmistowski B, Berbari EF, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469:2992–2994. doi:10.1007/s11999-011-2102-9

    Article  PubMed  PubMed Central  Google Scholar 

  12. McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M (2002) Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res 403:8–15

    Article  Google Scholar 

  13. Engh CA, Massin P, Suthers KE (1990) Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res 257:107–128

    Google Scholar 

  14. Kim YH, Kim VE (1993) Uncemented porous-coated anatomic total hip replacement. Results at six years in a consecutive series. J Bone Joint Surg (Br) 75(1):6–13

    CAS  Google Scholar 

  15. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56(1):1–10. doi:10.1093/cid/cis966

    Article  PubMed  Google Scholar 

  16. Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737–755

    Article  CAS  PubMed  Google Scholar 

  17. El-Husseiny M, Haddad FS (2016) The role of highly selective implant retention in the infected hip arthroplasty. Clin Orthop Relat Res. doi:10.1007/s11999-016-4936-7

    PubMed Central  Google Scholar 

  18. Ekpo TE, Berend KR, Morris MJ, Adams JB, Lombardi AV Jr (2014) Partial two-stage exchange for infected total hip arthroplasty: a preliminary report. Clin Orthop Relat Res 472:437–448. doi:10.1007/s11999-013-3168-3

    Article  PubMed  Google Scholar 

  19. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR (2006) Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42:471–478

    Article  CAS  PubMed  Google Scholar 

  20. Bjarnsholt T, Ciofu O, Molin S, Givskov M, Hoiby N (2013) Applying insights from biofilm biology to drug development—can a new approach be developed? Nat Rev Drug Discov 12:791–808. doi:10.1038/nrd4000

    Article  CAS  PubMed  Google Scholar 

  21. Gristina A (2004) Biomaterial centered infections: microbial adhesion versus tissue integration. Clin Orthop Relat Res 427:4–12

    Article  Google Scholar 

  22. Allison DG (2003) The biofilm matrix. Biofouling 19(2):139–150

    Article  CAS  PubMed  Google Scholar 

  23. Lee YK, Lee KH, Nho JH, Ha YC, Koo KH (2013) Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty: good results in 19 patients followed for mean 4 years. Acta Orthop 84(3):260–264. doi:10.3109/17453674.2013.795830

    Article  PubMed  PubMed Central  Google Scholar 

  24. Blomfeldt R, Kasina P, Ottosson C, Enocson A, Lapidus LJ (2015) Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. Int Orthop 39(11):2091–2096. doi:10.1007/s00264-015-2989-y

    Article  PubMed  Google Scholar 

  25. Leonard HA, Liddle AD, Burke O, Murray DW, Pandit H (2014) Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res 472:1036–1042. doi:10.1007/s11999-013-3294-y

    Article  PubMed  Google Scholar 

  26. Engesæter LB, Dale H, Schrama JC, Hallan G, Lie SA (2011) Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop 82:530–537. doi:10.3109/17453674.2011.623572

    Article  PubMed  PubMed Central  Google Scholar 

  27. Montanaro L, Testoni F, Poggi A, Visai L, Speziale P, Arciola CR (2011) Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int J Artif Organs 34(9):781–788. doi:10.5301/ijao.5000052

    Article  CAS  PubMed  Google Scholar 

  28. Upadhyayula VK, Gadhamshetty V (2010) Appreciating the role of carbon nanotube composites in preventing biofouling and promoting biofilms on material surfaces in environmental engineering: a review. Biotechnol Adv 28(6):802–816. doi:10.1016/j.biotechadv.2010.06.006

    Article  CAS  PubMed  Google Scholar 

  29. Veerachamy S, Yarlagadda T, Manivasagam G, Yarlagadda PK (2014) Bacterial adherence and biofilm formation on medical implants: a review. J Eng Med 228(10):1083–1099. doi:10.1177/0954411914556137

    Article  Google Scholar 

  30. Bakhsheshian J, Dahdaleh NS, Lam SK, Savage JW, Smith ZA (2014) The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence. World Neurosurg 83(5):816–823. doi:10.1016/j.wneu.2014.12.033

    Article  PubMed  Google Scholar 

  31. Sweet FA, Roh M, Sliva C (2011) Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions. Spine 36:2084–2088. doi:10.1097/BRS.0b013e3181ff2cb1

    Article  PubMed  Google Scholar 

  32. Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE (2004) Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg (Br) 86(4):504–509

    CAS  Google Scholar 

  33. Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ (2009) One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop 33(5):1195–1201. doi:10.1007/s00264-008-0640-x

    Article  PubMed  Google Scholar 

  34. Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Purchio TF, Contag PR (2004) Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo. Antimicrob Agents Chemother 48:2283–2287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K (2006) Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 50:55–61

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537–1541

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank LetPub for its linguistic assistance during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Cao.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Funding

Major Science and Technology Project of Xinjiang Uygur Autonomous Region (201430123–3).

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ji, B., Xu, B., Guo, W. et al. Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up. International Orthopaedics (SICOT) 41, 901–909 (2017). https://doi.org/10.1007/s00264-016-3291-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-016-3291-3

Keywords

Navigation